ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

IDD Innate Pharma

2.13
0.075 (3.65%)
22 Jul 2024 - Closed
Realtime Data
Share Name Share Symbol Market Type
Innate Pharma TG:IDD Tradegate Ordinary Share
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.075 3.65% 2.13 2.11 2.15 2.13 2.06 2.06 491 20:59:22

Issue of Loan Notes

14/10/2003 12:34pm

UK Regulatory


RNS Number:8699Q
ID Data PLC
14 October 2003


                    ID Data plc ("ID Data" or the "Company")

                                    Placing


Further to Company's announcement on 1 August 2003, ID Data is pleased to
announce that it has raised a further #1.15 million before expenses through the
issue of secured convertible loan notes 2008 ("Loan Notes") to institutional
investors (the "Placing").  The Placing brings the total funds raised by the
Company since 1 August 2003 to #4.15 million.

Peter Cox, Chief Executive, said: "This is further good news for ID Data and
highlights the confidence that the City has in the Company's business model and
strategy."

The proceeds of the issue of Loan Notes will provide additional working capital
to allow expansion of the business. Following today's issue of Loan Notes, ID
Data has issued in total #3.49 million of Loan Notes to date. The Company has
the authority to issue Loan Notes up to #4 million at any time prior to 31 March
2004.

The summary key terms of the Loan Note are as follows:
     
1.   The Company has the authority to issue Loan Notes with a nominal value up 
     to #4 million at any time prior to 31 March 2004;
     
2.   Interest is payable by the Company at 7 per cent. per annum, payable
     quarterly in arrears;
     
3.   The Loan Note converts at the rate of one Ordinary Share per 5.5p nominal 
     value of Loan Notes if issued prior to 31 August 2003 or, if issued after 
     this date, the higher of 5.5p and the average mid-market closing price of
     the Company's Ordinary Shares for the preceding three trading days to the 
     date of the issue of the Loan Note to the Loan Noteholder;
     
4.   The Company cannot require the Loan Noteholders to convert their Loan 
     Notes;

5.   The Directors have not applied, and do not intend to apply, to the London
     Stock Exchange or any other recognised investment exchange for the Loan
     Notes to be admitted to trading;
     
6.   The Loan Notes are transferable in amounts or integral multiples of #100; 
     and

7.  The Loan Notes are secured by a debenture issued by the Company over the
    assets of the Company.


For further information, please contact:
ID Data plc
Peter Cox                                             Tel: +44 (0) 1536 207000
enquiries@id-data.co.uk

Media Enquiries:
Bankside
Peter Curtain / Heather Salmond                       Tel: +44 (0) 20 7444 4140
heather.salmond@bankside.com


Notes to Editors:

ID Data plc ("ID Data") is the world's seventh-largest supplier of
secure-transaction systems and smart-card services to the international
telephony, banking, retail, and secure-access sectors. The Company's strategy,
to move from commodity products to value-added services and solutions, has
created a solid platform on which to build further growth. The Company's clients
include Vodafone, Nectar, Tesco, the Automobile Association, Exxon Mobil and, in
Poland, the Premium Club loyalty card scheme. ID Data has formed agreements with
major global corporations to facilitate rapid market development including
partnerships with Toshiba and Toppan. The Company has delivered in excess of 10
million chip cards to the banking market in the UK. The Company was founded in
1988 and was listed on the AIM market of the London Stock Exchange in October
2000.

www.id-data.co.uk


                      This information is provided by RNS
            The company news service from the London Stock Exchange
END
IODMIBBTMMJBBMJ

1 Year Innate Pharma Chart

1 Year Innate Pharma Chart

1 Month Innate Pharma Chart

1 Month Innate Pharma Chart